| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 336.85B | 316.83B | 276.08B | 252.71B | 226.34B | 213.00B |
| Gross Profit | 73.68B | 68.40B | 63.87B | 57.91B | 51.63B | 40.28B |
| EBITDA | 67.78B | 62.06B | 58.88B | 55.84B | 55.50B | 43.00B |
| Net Income | 22.42B | 19.93B | 19.83B | 18.85B | 15.67B | 9.71B |
Balance Sheet | ||||||
| Total Assets | 336.06B | 312.44B | 273.71B | 246.19B | 231.81B | 220.78B |
| Cash, Cash Equivalents and Short-Term Investments | 40.60B | 32.53B | 45.47B | 42.47B | 47.39B | 42.47B |
| Total Debt | 113.47B | 33.62B | 30.18B | 20.43B | 21.87B | 25.56B |
| Total Liabilities | 182.85B | 170.35B | 146.68B | 126.89B | 127.18B | 129.81B |
| Stockholders Equity | 151.81B | 140.68B | 125.75B | 118.12B | 103.53B | 89.96B |
Cash Flow | ||||||
| Free Cash Flow | 28.85B | 16.62B | 21.84B | 21.27B | 32.05B | 29.54B |
| Operating Cash Flow | 49.36B | 28.53B | 40.78B | 38.53B | 43.57B | 40.54B |
| Investing Cash Flow | -21.72B | -21.75B | -17.93B | -18.39B | -11.84B | -13.22B |
| Financing Cash Flow | -22.18B | -19.67B | -20.80B | -25.73B | -27.30B | -23.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥10.10T | 15.13 | 13.75% | 2.85% | 3.34% | 20.36% | |
63 Neutral | ¥14.14B | 47.06 | ― | 1.01% | 17.19% | -43.91% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥410.56B | 17.99 | 15.67% | 1.31% | 12.48% | 18.38% | |
60 Neutral | ¥10.18T | 18.01 | ― | 3.99% | 7.79% | 5.53% | |
56 Neutral | ¥312.57B | 19.02 | 17.97% | 1.36% | 4.75% | 17.02% | |
56 Neutral | ¥13.07T | 11.76 | 10.59% | 3.36% | 2.10% | -9.29% |